Jens Peter Klussmann

Professor and Chairman

Germany

Research Interests

Explore related searches

Professors in Germany Professors in Cancer Biology Cancer Biology professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Jens Peter Klussmann is a Professor and Chairman at the Medical Faculty of the University of Cologne, Germany. His research interests encompass various aspects of oncology, immunology, and advanced imaging techniques, as demonstrated in his recent articles focusing on T-cell dysregulation, HPV-related cancers, and tumor infiltrating lymphocytes. His work contributes significantly to understanding cancer mechanisms and improving therapeutic strategies.

Articles (13)

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (5)

Cornelia Brunner

Ulm University Medical Center

GERMANY

View details

Thorsten Lehr

Professor Clinical Pharmacy

Saarland University

GERMANY

View details

Ferdinand von Eggeling

Jena University Hospital

GERMANY

View details

Nora Wuerdemann

University of Cologne, Faculty of Medicine and University Hospital Cologne

GERMANY

View details

Srikanth Karnati

Justus Liebig University

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jens Peter Klussmann

Research Interests

Explore related searches

Contact this professor

About

Articles (13)

Local T-Cell Dysregulation and Immune Checkpoint Expression in Human Papillomavirus-Mediated Recurrent Respiratory Papillomatosis

Analysis of Expression and Regulation of AKR1C2 in HPV-Positive and -Negative Oropharyngeal Squamous Cell Carcinoma

Cochlear measurement in CT and MRI datasets by the OTOPLAN measurement tool: a retrospective comparative study

Predictors for Survival of Patients with Squamous Cell Carcinoma of Unknown Primary in the Head and Neck Region

Peroxisomes Are Highly Abundant and Heterogeneous in Human Parotid Glands

Pharmacometric Modeling of the Impact of Azelastine Nasal Spray on SARS-CoV-2 Viral Load and Related Symptoms in COVID-19 Patients

CD138 Is Expressed in Different Entities of Salivary Gland Cancer and Their Lymph Node Metastases and Therefore Represents a Potential Therapeutic Target

Patients with Pulmonary Metastases from Head and Neck Cancer Benefit from Pulmonary Metastasectomy, A Systematic Review

Reanimation of the Smile with Neuro-Vascular Anastomosed Gracilis Muscle: A Case Series

Patterns of Tumor Infiltrating Lymphocytes in Adenoid Cystic Carcinoma of the Head and Neck

Upfront Surgery vs. Primary Chemoradiation in an Unselected, Bicentric Patient Cohort with Oropharyngeal Squamous Cell Carcinoma—A Matched-Pair Analysis

Trophoblast Cell Surface Antigen 2 (Trop-2) Protein is Highly Expressed in Salivary Gland Carcinomas and Represents a Potential Therapeutic Target.

Deep Learning Predicts HPV Association in Oropharyngeal Squamous Cell Carcinomas and Identifies Patients with a Favorable Prognosis Using Regular H&E Stains

Collaborators (5)

Cornelia Brunner

Thorsten Lehr

Ferdinand von Eggeling

Nora Wuerdemann

Srikanth Karnati

Make your next move.